Abstract
It has been demonstrated by clinical and animal studies that stress stimulation plays a pivotal role in the tumor development and progression. Adrenergic system activation mediates most of the effects resulting from stress stimulation. Various cigarette components have been indicated for inducing the secretion of stress hormones such as noradrenaline and adrenaline which activate the adrenoceptors expressed on tumor cells and initiate different biological effects. Gastrointestinal (GI) cancers, a common malignancy in the body are also influenced by stress stimulation to a great extent. Combined stress stimulation with cigarette smoking can further accelerate tumor progression, and even develop chemoresistance in cancer cells. Therefore the involvement of adrenoceptors in these biological processes and habitual behaviours are becoming interesting therapeutic targets. Indeed various adrenoceptor blockers are implicated as promising therapeutic agents to prevent and treat relevant cancers including those in the GI tract. In this review, we sum up the possible relationship between the adrenergic system and GI cancers and provide a mechanistic understanding on this relationship. Meanwhile, we also further discuss the roles of cigarette smoke and its active ingredient nicotine which is highly associated with the adrenergic system in the development of GI cancers.
Keywords: Adrenergic system, adrenoceptors, β-blocker, GI cancers, nicotine, stress
Current Cancer Therapy Reviews
Title:The Adrenergic System in Gastrointestinal Cancers
Volume: 8 Issue: 2
Author(s): Zhi Jie Li and Chi Hin Cho
Affiliation:
Keywords: Adrenergic system, adrenoceptors, β-blocker, GI cancers, nicotine, stress
Abstract: It has been demonstrated by clinical and animal studies that stress stimulation plays a pivotal role in the tumor development and progression. Adrenergic system activation mediates most of the effects resulting from stress stimulation. Various cigarette components have been indicated for inducing the secretion of stress hormones such as noradrenaline and adrenaline which activate the adrenoceptors expressed on tumor cells and initiate different biological effects. Gastrointestinal (GI) cancers, a common malignancy in the body are also influenced by stress stimulation to a great extent. Combined stress stimulation with cigarette smoking can further accelerate tumor progression, and even develop chemoresistance in cancer cells. Therefore the involvement of adrenoceptors in these biological processes and habitual behaviours are becoming interesting therapeutic targets. Indeed various adrenoceptor blockers are implicated as promising therapeutic agents to prevent and treat relevant cancers including those in the GI tract. In this review, we sum up the possible relationship between the adrenergic system and GI cancers and provide a mechanistic understanding on this relationship. Meanwhile, we also further discuss the roles of cigarette smoke and its active ingredient nicotine which is highly associated with the adrenergic system in the development of GI cancers.
Export Options
About this article
Cite this article as:
Jie Li Zhi and Hin Cho Chi, The Adrenergic System in Gastrointestinal Cancers, Current Cancer Therapy Reviews 2012; 8 (2) . https://dx.doi.org/10.2174/157339412800675379
DOI https://dx.doi.org/10.2174/157339412800675379 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue will focus on key areas such as lipid nanoparticles, mRNA therapeutics, drug delivery systems, nanotechnology in medicine, targeted therapy, non-viral vectors, precision medicine, and biomedical engineering.read more
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Opioids Resistance in Chronic Pain Management
Current Neuropharmacology Potential Role of <i>In Vitro-In Vivo</i> Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs
Current Drug Targets Chronopharmaceutics: A Promising Drug Delivery Finding of the Last Two Decades
Recent Patents on Drug Delivery & Formulation Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
Current Medicinal Chemistry Structural Biology of Bacterial Secretion Systems in Gram-Negative Pathogens- Potential for New Drug Targets
Infectious Disorders - Drug Targets A proteomics based approach for the identification of gastric cancer related markers
Current Pharmaceutical Design Anthelmintic Therapy in Ruminant Species: Understanding of the Host-Drug-Parasite Interaction
Anti-Infective Agents in Medicinal Chemistry MICA Molecules in Disease and Transplantation, a Double-Edged Sword?
Current Immunology Reviews (Discontinued) DNA Polymerases as Targets of Anticancer Nucleosides
Current Drug Targets A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer
Clinical Cancer Drugs PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Anti-Cancer Agents in Medicinal Chemistry The Clinical Impact of Quantitative Cell-free DNA, KRAS, and BRAF Mutations on Response to Anti-EGFR Treatment in Patients with Metastatic Colorectal Cancer
Current Pharmaceutical Design Therapeutic Potential of Plant Extracts and Phytochemicals Against Brain Ischemia-Reperfusion Injury: A Review
The Natural Products Journal Epidermolysis Bullosa: The Pediatricians Role
Current Pediatric Reviews Depigmentation and Anti-aging Treatment by Natural Molecules
Current Pharmaceutical Design GLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Current Clinical Pharmacology Natural Alpha-Glucosidase Inhibitors: Therapeutic Implication and Structure- Activity Relation Ship
Letters in Drug Design & Discovery Axitinib in the Treatment of Head and Neck Malignancies
Current Clinical Pharmacology Safety of One-week, First-line, Standard Triple Therapy for Helicobacter pylori Eradication in a Japanese Population
Current Drug Safety Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway
Current Cancer Drug Targets